|
1
|
Dinarello CA: Historical insights into
cytokines. Eur J Immunol. 37 (Suppl 1):S34–S45. 2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Turner MD, Nedjai B, Hurst T and
Pennington DJ: Cytokines and chemokines: At the crossroads of cell
signalling and inflammatory disease. Biochim Biophys Acta.
1843:2563–2582. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Juhn SK, Jung MK, Hoffman MD, Drew BR,
Preciado DA, Sausen NJ, Jung TT, Kim BH, Park SY, Lin J, et al: The
role of inflammatory mediators in the pathogenesis of otitis media
and sequelae. Clin Exp Otorhinolaryngol. 1:117–138. 2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Skovbjerg S, Roos K, Nowrouzian F, Lindh
M, Holm SE, Adlerberth I, Olofsson S and Wold AE: High cytokine
levels in perforated acute otitis media exudates containing live
bacteria. Clin Biol Infect. 16:1382–1388. 2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Regnault V, de Maistre E, Carteaux JP,
Gruel Y, Nguyen P, Tardy B and Lecompte T: Platelet activation
induced by human antibodies to interleukin-8. Blood. 101:1419–1421.
2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bester J and Pretorius E: Effects of
IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot
viscoelasticity. Sci Rep. 6(32188)2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Skotnicka B and Hassmann E:
Proinflammatory and immunoregulatory cytokines in the middle ear
effusions. Int J Pediatr Otorhinolaryngol. 72:13–17.
2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Artono Surarto B, Purnami N, Hutahaen F
and Mahardhika MR: The association of IL-1 alpha level and TNF
alpha expressions on bone destruction in chronic suppurative otitis
media and cholesteatoma. Indian J Otolaryngol Head Neck Surg.
72:1–7. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kuczkowski J, Sakowicz-Burkiewicz M,
Iżycka-Świeszewska E, Mikaszewski B and Pawełczyk T: Expression of
tumor necrosis factor-α, interleukin-1α, interleukin-6 and
interleukin-10 in chronic otitis media with bone osteolysis. ORL J
Otorhinolaryngol Relat Spec. 73:93–9. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Alves AL and Ribeiro FAQ: The role of
cytokines in acquired middle ear cholesteatoma: Literature review.
Rev Bras Otorrinol. 70:813–818. 2004.
|
|
11
|
Didierjean L, Salomon D, Mèrot Y,
Siegenthaler G, Shaw A, Dayer JM and Saurat JH: Localization and
characterization of the interleukin 1 immunoreactive pool (IL-1
alpha and beta forms) in normal human epidermis. J Invest Dermatol.
92:809–816. 1989.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kishimoto T: The biology of interleukin-6.
Blood. 74:1–10. 1989.PubMed/NCBI
|
|
13
|
Yellon RF, Doyle WJ, Whiteside TL, Diven
WF, March AR and Fireman P: Cytokines, immunoglobulins, and
bacterial pathogens in middle ear effusions. Arch Otolaryngol Head
Neck Surg. 121:865–869. 1995.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kerschner JE, Meyer TK, Yang C and Burrows
A: Middle ear epithelial mucin production in response to
interleukin-6 exposure in vitro. Cytokine. 26:30–36.
2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wu Y, Tang X, Shao W and Lu Y: Effect of
CT manifestations of cholesteatoma on MMP-2, MMP-9 and IL-6 in the
serum of patients. Exp Ther Med. 17:4441–4446. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nofal K and Kwatly K: Serum interleukin-6
and C-reactive protein in bacterial otitis media patients in
Damascus city. Int J Chem Farm. 7:403–408. 2015.
|
|
17
|
Liu W, Xie S, Chen X, Rao X, Ren H, Hu B,
Yin T, Xiang Y and Ren J: Activation of the IL-6/JAK/STAT3
signaling pathway in human middle ear cholesteatoma epithelium. Int
J Clin Exp Pathol. 7:709–715. 2014.PubMed/NCBI
|
|
18
|
Schröder JM: The neutrophil-activating
peptide 1/interleukin 8, a novel neutrophil chemotactic cytokine.
Arch Immunol Ther Exp (Warsz). 40:23–31. 1992.PubMed/NCBI
|
|
19
|
Takeuchi K, Maesako K, Yuta A and Sakakura
Y: Interleukin-8 gene expression in middle ear effusions. Ann Otol
Rhinol Laryngol. 103:404–407. 1994.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Butnaru C, Serban R, Martu C, Lungu A,
Doroftei EA, Cobzeanu B and Cozma S: Otitis media complications.
In: Proceeding of National ENT Head and Neck Surgery Conference.
Berteșteanu SVG and Grigore R (eds). Filodiritto Publ., Arad,
pp102-106, 2018.
|
|
21
|
Hotomi M, Samukawa T and Yamanaka N:
Interleukin-8 in otitis media with effusion. Acta Otolaryngol.
114:406–409. 1994.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sato K, Liebeler CL, Quartey MK, Le CT and
Giebink GS: Middle ear fluid cytokine and inflammatory cell
kinetics in the chinchilla otitis media model. Infect Immun.
67:1943–1946. 1999.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Schürmann M, Greiner JFW, Volland-Thurn V,
Oppel F, Kaltschmidt C, Sudhoff H and Kaltschmidt B: Stem
cell-induced inflammation in cholesteatoma is inhibited by the TLR4
antagonist LPS-RS. Cells. 9(199)2020.PubMed/NCBI View Article : Google Scholar
|
